Researchers at the University of California San Diego are hoping to drastically shorten the time between a cancer diagnosis ...

Nuvectis Pharma (NVCT) stock falls as company posts interim data from a Phase 1b trial for its ovarian cancer drug candidate.

Researchers found significant differences in ovarian cancer survival among Asian American subgroups, emphasizing the ...

Researchers from the Walter and Eliza Hall Institute (WEHI)in Australia have found a new way to predict a subset of patients ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...

A simple blood test could soon predict which ovarian cancer patients will stop responding to their treatment, paving the way ...

University of Iowa researchers have landed a $10-million federal grant to develop a new treatment for ovarian cancer. Jill ...

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- ...

Ovarian cancer is the sixth most common cancer in women in the UK but the symptoms can be quite subtle, often leaving to a ...

A University of iowa research project wins a 10-million dollar federal grant to combat ovarian cancer.UI College Of Pharmacy ...

Researchers discovered that ovarian tumors hinder T cells' energy supply by trapping a key protein, blocking lipid uptake. A ...

Though GSK has put considerable effort into developing pharmacological treatments for gynecological cancers—including Zejula, ...